読み込み中
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.
前日終値
$13.00
+$0.76 · +6.21%
日中の時刻はETです。市場データは遅延する場合があります。
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.
日中レンジ
現在 $13.00
52週レンジ
現在 $13.00
日中の時刻はETです。市場データは遅延する場合があります。
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.
日中レンジ
現在 $13.00
52週レンジ
現在 $13.00
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$37.00
上昇余地（184.62%）この株式へのエクスポージャーを報告している上場投資信託です。
Schwab U.S. Small-Cap ETFSCHA296.23万0.01%218.24億 USD0.03%$32.79+0.40%
Guggenheim Funds Trust - Guggenheim Securitized Income ETFGISC118.3万0.09%6790万 USD0.47%$49.2511+0.08%
Guggenheim Funds Trust - Guggenheim Ultra Short Income ETFGCSH118.3万0.03%1.46億 USD0.25%$49.85+0.02%
iShares Core S&P Total U.S. Stock Market ETFITOT75.68万0.00%980.88億 USD0.03%$169.66+0.64%
Schwab U.S. Broad Market ETFSCHB35万0.00%453.77億 USD0.03%$29.91+0.61%
Fidelity Nasdaq Composite Index ETFONEQ20.18万—109.4億 USD0.21%$107.81+0.63%
T. Rowe Price Innovation Leaders ETFTNXT7772.40.04%1966.95万 USD0.49%$29.155+1.22%Schwab U.S. Small-Cap ETFSCHAGuggenheim Funds Trust - Guggenheim Securitized Income ETFGISCGuggenheim Funds Trust - Guggenheim Ultra Short Income ETFGCSHiShares Core S&P Total U.S. Stock Market ETFITOTSchwab U.S. Broad Market ETFSCHBFidelity Nasdaq Composite Index ETFONEQT. Rowe Price Innovation Leaders ETFTNXTAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
